Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT02572843 · COMPLETED
Trial details
- NCT number
- NCT02572843
- Sponsor
- Swiss Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-16
- Primary completion
- 2020-01-20
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.